http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2019008847-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b03b63dcb77a2269515f7c17cdee4a66
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C329-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00
filingDate 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d382deaf95d51703df1a8b74f06cb7
publicationDate 2019-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2019008847-A
titleOfInvention CYSTEAMINE DEPTH DRUGS.
abstract Described herein are cysteamine prodrugs and pharmaceutically acceptable salts, solvates, and esters thereof. Also described herein are pharmaceutical compositions comprising prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates and esters thereof and methods of treatment comprising administering prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates and esters thereof.
priorityDate 2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457578503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6058

Total number of triples: 21.